Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives


SYDNEY, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q), the Company developing a new class of synthetic anti-infectives, today announced the Australian Patent Office has formally granted Recce a family three patent for its anti-infectives, with expiry in 2037.

Read the original:
Recce Pharmaceuticals Granted Australia Patent for RECCE® Anti-Infectives

Related Posts